HCA Healthcare (NYSE:HCA) PT Raised to $250.00

HCA Healthcare (NYSE:HCA) had its price target boosted by BMO Capital Markets from $235.00 to $250.00 in a report released on Wednesday, The Fly reports. BMO Capital Markets currently has a market perform rating on the stock.

HCA has been the topic of several other research reports. Truist Securities lifted their target price on HCA Healthcare from $200.00 to $230.00 and gave the company a buy rating in a research note on Wednesday, April 14th. Jefferies Financial Group restated a buy rating on shares of HCA Healthcare in a report on Friday, June 18th. Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $210.00 to $225.00 and gave the company a buy rating in a report on Monday, April 26th. Truist raised their price target on HCA Healthcare from $200.00 to $230.00 in a report on Wednesday, April 14th. Finally, Seaport Global Securities initiated coverage on HCA Healthcare in a report on Friday, July 9th. They set a buy rating and a $235.00 price target for the company. They noted that the move was a valuation call. Four analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of $231.48.

HCA stock opened at $249.25 on Wednesday. HCA Healthcare has a fifty-two week low of $114.38 and a fifty-two week high of $254.45. The firm has a 50-day moving average price of $212.68. The company has a debt-to-equity ratio of 18.06, a quick ratio of 1.15 and a current ratio of 1.45. The company has a market capitalization of $82.41 billion, a P/E ratio of 17.10, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Monday, July 19th. The company reported $4.37 EPS for the quarter, topping the consensus estimate of $3.16 by $1.21. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The firm had revenue of $14.44 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter last year, the company earned $3.23 earnings per share. The business’s revenue for the quarter was up 30.4% compared to the same quarter last year. On average, sell-side analysts anticipate that HCA Healthcare will post 16.7 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 30th. Investors of record on Thursday, September 16th will be paid a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date of this dividend is Wednesday, September 15th. HCA Healthcare’s dividend payout ratio is currently 16.54%.

In other news, SVP Robert A. Waterman sold 147,534 shares of the business’s stock in a transaction on Friday, April 30th. The stock was sold at an average price of $200.68, for a total value of $29,607,123.12. Following the completion of the transaction, the senior vice president now directly owns 270,090 shares of the company’s stock, valued at approximately $54,201,661.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider A Bruce Moore, Jr. sold 12,000 shares of the business’s stock in a transaction on Monday, May 3rd. The stock was sold at an average price of $205.32, for a total value of $2,463,840.00. Following the transaction, the insider now owns 102,381 shares in the company, valued at $21,020,866.92. The disclosure for this sale can be found here. Insiders have sold a total of 342,446 shares of company stock valued at $68,773,585 over the last three months. 1.60% of the stock is owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD grew its stake in HCA Healthcare by 9.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 25,160,741 shares of the company’s stock worth $4,137,911,000 after buying an additional 2,231,318 shares during the last quarter. Sanders Capital LLC grew its stake in HCA Healthcare by 1.6% during the 1st quarter. Sanders Capital LLC now owns 7,795,555 shares of the company’s stock worth $1,564,339,000 after buying an additional 121,700 shares during the last quarter. JPMorgan Chase & Co. grew its stake in HCA Healthcare by 111.3% during the 1st quarter. JPMorgan Chase & Co. now owns 4,777,608 shares of the company’s stock valued at $899,815,000 after purchasing an additional 2,516,289 shares during the last quarter. Norges Bank purchased a new stake in HCA Healthcare during the 4th quarter valued at about $548,149,000. Finally, Bank of New York Mellon Corp grew its stake in HCA Healthcare by 11.9% during the 1st quarter. Bank of New York Mellon Corp now owns 2,968,099 shares of the company’s stock valued at $559,011,000 after purchasing an additional 314,801 shares during the last quarter. Hedge funds and other institutional investors own 68.68% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Article: Non-Fungible Token (NFT) Explained

The Fly logo

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.